CB2 cannabinoid receptor activation produces antinociception by stimulating peripheral release of endogenous opioids - Wikidata - wikimedia - TriplyDB

CB2 cannabinoid receptor activation produces antinociception by stimulating peripheral release of endogenous opioids

CB2 cannabinoid receptor activation produces antinociception by stimulating peripheral release of endogenous opioids

http://www.wikidata.org/entity/Q24556619

about

In vitro pharmacological characterization of AM1241: a protean agonist at the cannabinoid CB2 receptor?The endocannabinoid system, cannabinoids, and pain New insights into the pathophysiology and treatment of chronic itch in patients with end-stage renal disease, chronic liver disease, and lymphoma A cannabinoid 2 receptor agonist attenuates bone cancer-induced pain and bone loss Is lipid signaling through cannabinoid 2 receptors part of a protective system?Crucial role of CB(2) cannabinoid receptor in the regulation of central immune responses during neuropathic pain In vitro and in vivo characterization of A-796260: a selective cannabinoid CB2 receptor agonist exhibiting analgesic activity in rodent pain models Beta-caryophyllene is a dietary cannabinoid The endocannabinoid system as an emerging target of pharmacotherapy Species-specific in vitro pharmacological effects of the cannabinoid receptor 2 (CB2) selective ligand AM1241 and its resolved enantiomers The cannabinoid WIN 55,212-2 inhibits transient receptor potential vanilloid 1 (TRPV1) and evokes peripheral antihyperalgesia via calcineurin Biologic mechanisms of oral cancer pain and implications for clinical therapy Evidence for a role of endocannabinoids, astrocytes and p38 phosphorylation in the resolution of postoperative pain β-caryophyllene and β-caryophyllene oxide-natural compounds of anticancer and analgesic properties A pilot trial of low-dose naltrexone in primary progressive multiple sclerosis Targeting cannabinoid agonists for inflammatory and neuropathic pain Contributions of academic laboratories to the discovery and development of chemical biology tools Effects of a selective cannabinoid CB2 agonist and antagonist on intravenous nicotine self administration and reinstatement of nicotine seeking Involvement of peripheral cannabinoid and opioid receptors in β-caryophyllene-induced antinociception Opposing roles of mGluR8 in measures of anxiety involving non-social and social challenges.Acute pharmacological modulation of mGluR8 reduces measures of anxiety.Peripherally acting mu-opioid receptor agonist attenuates neuropathic pain in rats after L5 spinal nerve injury Peripheral gating of pain signals by endogenous lipid mediators.Cannabinoid-opioid interactions during neuropathic pain and analgesia.Antinociceptive effects of racemic AM1241 and its chirally synthesized enantiomers: lack of dependence upon opioid receptor activation.2012 Division of medicinal chemistry award address. Trekking the cannabinoid road: a personal perspective Cannabinoid CB1 receptor facilitation of substance P release in the rat spinal cord, measured as neurokinin 1 receptor internalization.Mechanism of cancer pain.Cannabinoid WIN 55,212-2 regulates TRPV1 phosphorylation in sensory neurons.The antinociceptive effects of JWH-015 in chronic inflammatory pain are produced by nitric oxide-cGMP-PKG-KATP pathway activation mediated by opioids CB2: a cannabinoid receptor with an identity crisis Pharmacological characterization of a novel cannabinoid ligand, MDA19, for treatment of neuropathic pain Skin β-endorphin mediates addiction to UV light The neurobiology of cancer pain.CB2 Cannabinoid receptors as a therapeutic target-what does the future hold?Brain cannabinoid CB₂ receptors modulate cocaine's actions in mice Functional characterization and analgesic effects of mixed cannabinoid receptor/T-type channel ligands.Sensing the environment: regulation of local and global homeostasis by the skin's neuroendocrine system.Topical analgesics for neuropathic pain: preclinical exploration, clinical validation, future development.Medical marijuana in neurology.

P2860

Q24564956-494DFBA5-36F4-4BEA-877E-C4F9B5810B9F Q24601890-9749C481-ABEA-47E0-B69D-8B326406DA0A Q24615751-D4BC23AC-B48E-4BB1-A275-844CA0E149FA Q24615787-39F8CDAC-E9E9-4CB6-99C4-0800529485DC Q24633122-B10EEA55-3C4F-4D31-BB43-AD038DE3C256 Q24634161-BA084BC5-9193-44BE-AE5A-7DD231E7F1A1 Q24643672-1071CC94-6973-467E-9166-334C6B172A6C Q24645478-6E035B7F-2D10-489F-94D9-9243D6D00FCD Q24648473-9E92796B-2EAC-4C94-A6C9-AB5321DEAE27 Q24673335-8CCAC234-3690-4096-A265-096A0662F28C Q24676808-37707592-6939-4C3E-AA45-BDA7DDC94FDF Q26865216-E4D60995-C70C-4743-8883-CE7BA9C15D59 Q27325738-84902EE9-1061-4132-B46E-041575E76FB8 Q28078891-1F53F018-1A9D-4BB6-8F9E-C00932EC4A2B Q28291875-64756728-436F-4C9D-80D0-A08352D669B2 Q28307619-F35570CC-A165-48C6-9097-0AF6650473C4 Q28389188-09D76E75-5885-430B-89A9-E2C766AF5554 Q28480387-C468D155-3DFF-4780-9E42-51BDFD3AB7AB Q29395820-764F5506-C71A-4F5D-9C03-BD34E75B8B30 Q30465038-520B381A-5CDE-4081-9545-6EFA110D7538 Q30473719-6E826EA3-7D11-462B-A107-576ECBD49C14 Q33585535-0A3AAC5E-51C2-4D04-A073-5496A7BF40D3 Q33608432-C2259E32-1583-4630-A9E8-A9358906A2F3 Q33637224-4CA29829-CC77-416D-8944-8AD382353C8E Q33749455-29BF0988-CA4B-452C-8CD1-D9D7DC4DABC0 Q33781776-C8DFA753-98FF-445C-B2C0-11F7150C9F71 Q33803774-5FC14ADF-AAE8-4224-81CC-CAB1ECF0CCD9 Q33953901-0AD275A7-D427-4D97-BDEA-DE70666ED90A Q34023746-E74601E6-FC37-4D8D-A4EC-33C566CFA0A7 Q34059667-C92458A3-AC02-4E9E-81DA-C0A7F56366CE Q34098185-C7D42D01-31DE-4D25-82BF-AE2D0212221A Q34118976-BD4A5F68-CF74-4F1C-9CA4-7240042D3973 Q34161442-48D252EC-F68F-4DA4-A942-CE1B7EE2F799 Q34167635-90AC6004-84F4-4A63-9505-0EF216D4C0A0 Q34186015-BBB03DC1-46CA-4173-BCF6-C703CA3D0050 Q34203193-ACCF7F81-A045-4EFA-9DFA-6F5F3640F468 Q34233536-98D00B75-0223-4024-A9F6-152668DB4B6F Q34294075-DA82BA7C-C60C-4F18-B1F6-A5B0ADFA61C2 Q34376548-55FAC00D-953B-4357-9BF1-DE1F4F511C23 Q34449698-B32091A1-E82D-4C57-B696-CA649CF0797D

P2860

CB2 cannabinoid receptor activation produces antinociception by stimulating peripheral release of endogenous opioids

http://www.wikidata.org/entity/Q24556619

description

2005 nî lūn-bûn

@nan

2005 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

name

CB2 cannabinoid receptor activ ...... release of endogenous opioids

@ast

CB2 cannabinoid receptor activ ...... release of endogenous opioids

@en

CB2 cannabinoid receptor activ ...... release of endogenous opioids

@nl

type

label

CB2 cannabinoid receptor activ ...... release of endogenous opioids

@ast

CB2 cannabinoid receptor activ ...... release of endogenous opioids

@en

CB2 cannabinoid receptor activ ...... release of endogenous opioids

@nl

prefLabel

CB2 cannabinoid receptor activ ...... release of endogenous opioids

@ast

CB2 cannabinoid receptor activ ...... release of endogenous opioids

@en

CB2 cannabinoid receptor activ ...... release of endogenous opioids

@nl

P1433

Q24556619-6A7FF7B1-C420-47AD-B3A7-D59C0F828DB9

P1476

Q24556619-7EF776E5-64B6-45EF-A681-D7551D370B44

P2093

Q24556619-012FCB7A-1930-4EF5-8E6F-B30A5F07B730

Q24556619-4988DEDC-1309-40F8-8444-3798A94D914B

Q24556619-59626351-50E7-4362-9521-18490F3C5BE7

Q24556619-5A89F785-8828-4317-9E54-BEFF86598E06

Q24556619-6FCD9B24-0EA9-4899-9CCD-02D2A3CB47EC

Q24556619-C5EB3EE1-E9AD-4423-A317-6547CD27E058

Q24556619-D8DADB3C-D5B0-41C3-9664-83279D491194

Q24556619-F3C9155E-EC90-4FBA-9E1E-7919E7D3CBDB

P2860

Q24556619-02FC5722-CA6C-4792-9234-F09EC2AFBE29

Q24556619-063E5B90-2F07-41FD-8DF5-F8129A2F29B6

Q24556619-06D0BC3E-0B56-485B-B552-0709292EFAA4

Q24556619-08D02F6D-5418-4AE7-9877-187CED8FABCC

Q24556619-15294F28-A541-464E-BC04-252C0FE782C5

Q24556619-240C063B-8A31-4692-8ECC-359FC048159D

Q24556619-2582DA51-5669-461C-87A9-3EAB8FA2D3F9

Q24556619-2A1EDF81-4BF5-4F87-BDB2-438033792FC7

Q24556619-33E66623-5866-4A54-844D-F90C59CC93ED

Q24556619-4B96BB0C-B89A-433F-A86A-75D88DA4D816

P304

Q24556619-FF30F9CB-49F1-4706-80D0-8D0FE14FFC06

P31

Q24556619-0611D652-226A-4F7F-A00E-CAD2BC4981A8

P3181

Q24556619-6EE09185-B656-4A06-AC64-CED304DCD506

P356

Q24556619-2EFB3367-005A-423C-A68B-CA038F05FAE9

P407

Q24556619-4A2A17B8-D04F-42F1-A4C1-FF78A6218E89

P433

Q24556619-644A87C9-A426-48E0-8502-E10D89C8BF59

P478

Q24556619-5E2B1A91-4B31-416E-999C-9678138A195C

P50

Q24556619-44A29EF9-8D68-45DC-B442-D776331C2879

Q24556619-727B0CA4-6594-4779-ACC9-6D5903067097

Q24556619-89885C74-EFE4-4C18-9B71-25E1E41A46E1

P577

Q24556619-D5F0DE91-6A64-4619-AB1E-8BC56CB22904

P5875

Q24556619-BFA0F24D-9ACA-47EA-99EC-1D6937E28F45

P698

Q24556619-9C1F5D1C-82B8-4884-B770-F52FEDCA29F5

P921

Q24556619-08A8889E-FCA2-44CA-9B43-DCE7F496AADB

Q24556619-25fd0b8c-2b69-4685-a2af-473d243da2af

Q24556619-BC1BEE34-E1AA-4886-8C97-E8F6EF141D91

Q24556619-F3CE4742-CA61-47D6-833D-6B91762C5AEF

P932

Q24556619-71BC5A6F-6DDD-48BA-839E-982356D0B51A

P3181

P356

PNAS.0409888102

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

CB2 cannabinoid receptor activ ...... release of endogenous opioids

@en

P2093

Alla Khodorova

http://www.w3.org/2001/XMLSchema#string

Frank L Rice

http://www.w3.org/2001/XMLSchema#string

Gudarz Davar

http://www.w3.org/2001/XMLSchema#string

Heriberto P Mata

http://www.w3.org/2001/XMLSchema#string

Mohab M Ibrahim

http://www.w3.org/2001/XMLSchema#string

Phillip J Albrecht

http://www.w3.org/2001/XMLSchema#string

T Philip Malan

http://www.w3.org/2001/XMLSchema#string

Todd W Vanderah

http://www.w3.org/2001/XMLSchema#string

P2860

Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations

Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors

Agonist-inverse agonist characterization at CB1 and CB2 cannabinoid receptors of L759633, L759656, and AM630

Activation of CB2 cannabinoid receptors by AM1241 inhibits experimental neuropathic pain: pain inhibition by receptors not present in the CNS

Molecular characterization of a peripheral receptor for cannabinoids

Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice

HU-308: a specific agonist for CB(2), a peripheral cannabinoid receptor

Endothelin-B receptor activation triggers an endogenous analgesic cascade at sites of peripheral injury

Opiate receptor knockout mice define mu receptor roles in endogenous nociceptive responses and morphine-induced analgesia

The peripheral cannabinoid receptor: adenylate cyclase inhibition and G protein coupling

P304

3093-8

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3248570

http://www.w3.org/2001/XMLSchema#string

P356

10.1073/PNAS.0409888102

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

102

http://www.w3.org/2001/XMLSchema#string

P50

Alexandros Makriyannis

P577

2005-02-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8026810

http://www.w3.org/2001/XMLSchema#string

P698

15705714

http://www.w3.org/2001/XMLSchema#string

P921

cannabinoid receptor

P932

549497

http://www.w3.org/2001/XMLSchema#string